UPDATE: Deutsche Bank Raises Medicis Pharmaceuticals' PT

According to research report published this morning, Deutsche Bank has increased Medicis Pharmaceuticals'

PT from $41 to $44. Deutsche Bank commented in the report, “On Tuesday, we hosted an in-depth meeting with Medicis management which included a detailed look at the company's key marketed products, development pipeline, business development activities, and growth outlook. Given our positive bias post this company visit, in tandem with positive momentum on the recent Zyclara launch, we continue to rate Medicis shares Buy.” Medicis Pharmaceuticals closed yesterday at $38.23.